488
Views
61
CrossRef citations to date
0
Altmetric
Review

Criteria for deep-brain stimulation in Parkinson’s disease: review and analysis

&
Pages 1695-1705 | Published online: 09 Jan 2014

References

  • Bower JH, Maraganore DM, McDonnel SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990. Neurology52, 1214–1220 (1999).
  • De Rijk MC, Breteler MMB, Graveland GA. Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurological Disease in the Elderly Research Group. Neurology54, S21–S23 (2000).
  • Lang AE, Lozano AM. Parkinson’s disease. First of two parts. N. Engl. J. Med.339, 1044–1053 (1998).
  • Clayton DF, George JM. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci.21, 249–254 (1998).
  • Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res.318, 121–134 (2004).
  • Feldman RG, Ratner MH. The pathogenesis of neurodegenerative disease: neurotoxic mechanisms of action and genetics. Curr. Opin. Neurol.12, 725–731 (1999).
  • Zhang Y, Dawson VL, Dawson TM. Oxidative stress and genetics in the pathogenesis of Parkinson’s disease. Neurobiol. Dis.7, 240–250 (2000).
  • Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, ‘prefrontal’ and ‘limbic’ functions. Prog. Brain Res.85, 119–146 (1990).
  • Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res.20, 91–127 (1995).
  • Middleton FA, Strick PL. Basal ganglia and cerebellar loop: motor and cognitive circuits. Brain Res.31, 236–250 (2000).
  • Temel Y, Blokland A, Steinbush HWM, Visser-Vanderwalle V. The functional role of the subthalamic nucleus in cognitive and limbic circuits. Progress. Neurobiol.76, 393–413 (2005).
  • Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci.12, 366–375 (1989).
  • Miller WC, DeLong MR. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. The Basal Ganglia II. Carpenter MB, Jayaraman A (Eds). Plenum Press, NY, USA 415–427 (1987).
  • Smith Y, Bevan MD, Shink E, Bolam JP. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience86, 353–387 (2000).
  • Levy R, Hutchison WD, Lozano AM, Dostrovsky JO. High frequency synchronization of neuronal activity in the subthlamic nucleus of parkinsonian patients with tremor. J. Neurosci.20, 7766–7775 (2000).
  • Marsden JF, Limousin-Dowsey P, Ashby P, Pollak P, Brown P. Subthalamic nucleus, sensorimotor cortex and muscle interrelationship in Parkinson’s disease. Brain124, 378–388 (2001).
  • Lang AE, Obeso JA. Time to move beyond nigrostriatal dopamine deficiency in Parkinson’s disease. Ann. Neurol.55, 761–765 (2004).
  • Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE. Pathological gambling caused by drugs used to treat Parkinson’s disease. Arch. Neurol.62, 1377–1381 (2005).
  • Lozano AM, Lang AE. Pallidotomy for Parkinson’s disease. Neurosurg. Clin. N. Am.9, 325–336 (1998).
  • Benabid AL, Pollak P, Gervason C et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet337, 403–406 (1991).
  • Benazzoz A, Gross C, Feger J et al. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur. J. Neurosci.5, 382–389 (1993).
  • Pollak P, Benabid AL, Gross C et al. Effects of the stimulation of the subthalamic nucleus in Parkinson’s disease. Rev. Neurol. (Paris)149, 175–176 (1993).
  • Sigfried J, Lippitz B. Bilateral chronic electrostimulation of the ventroposterolateral pallidum: a new therapeutic approach for alleviating parkinsonian symptoms. Neurosurg.35, 1126–1130 (1994).
  • Kumar R, Lozano AM, Kim YJ et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Neurology51(3), 850–855 (1998).
  • Ostergaard K, Sunde N, Dupont E. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson’s disease and motor fluctuations. Mov. Disord.17, 693–700 (2002).
  • Krack P, Batir A, Van Blercom N et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N. Engl. J. Med.349(20), 1925–1934 (2003).
  • Pahwa R, Wilkinson SB, Overman J, Lyons KE. Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow-up. J. Neurosurg.99, 71–77 (2003).
  • Rodriguez-Oroz MC, Obeso JA, Lang AE et al. Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain128, 2240–2249 (2005).
  • Schupbach WMM, Chastan N, Welter ML et al. Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5-year follow up. J. Neurol. Neurosurg. Psychiatr.76, 1640–1644 (2005).
  • Dostrovsky JO, Lozano AM. Mechanisms of deep brain stimulation. Mov. Disord.17(Suppl. 3), S63–S68 (2002).
  • Houeto JL, Damier P, Bejjani PB et al. Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch. Neurol.57(4), 461–465 (2000).
  • Pollak P, Benabid AL, Krack P et al. Deep brain stimulation. In: Parkinson’s Disease and Movement Disorder (3rd Edition). Jankovich J, Tolosa E (Eds). Williams & Wilkins, MD, USA, 1085–1101 (1998).
  • Charles PD, Van Blercom N, Krack P et al. Predictors of effective bilateral subthalamic nucleus stimulation for Parkinson’s disease. Neurology59(6), 932–934 (2002).
  • Welter ML, Houeto JL, Tezenas de Montcel S et al. Clinical predictive factors of subthalamic stimulation in Parkinson’s disease. Brain125, 575–583 (2002).
  • Lang AE, Widner H. Deep brain stimulation for Parkinson’s disease: patient selection and evaluation. Mov. Disord.17(Suppl. 3), S94–S101 (2002).
  • Defer GL, Widner H, Marie RM, and the Conference participants. Core Assessment Program for Surgical Interventional Therapies in Parkinson’s disease (CAPSIT-PD). Mov. Disord.14, 572–584 (1999).
  • Lang AE, Houeto JL, Krack P et al. Deep brain stimulation: preoperative issues. Mov. Disord.21(Suppl. 14), S171–S196 (2006).
  • Voon V, Saint-Cyr JA, Lozano AM, Moro E, Poon YY, Lang AE. Psychiatric symptoms in patients with Parkinson’s disease presenting for deep stimulation surgery. J. Neurosurg.103, 246–251 (2005).
  • Berney A, Vingerhoets F, Perrin A et al. Effect on mood of subthalamic deep brain stimulation (DBS) for Parkinson’s disease: a consecutive series of 24 patients. Neurology59, 1427–1429 (2002).
  • Okun MS, Fernandez HH, Pedraza O et al. Development and initial validation of a screening tool for Parkinson disease surgical candidates. Neurology63, 161–163 (2004).
  • Okun MS, Tagliati M, Porfar M et al. Management of referred deep brain stimulation failure. Arch. Neurol.62, 1250–1255 (2005).
  • Deep Brain Stimulation for Parkinson’s Disease. Lang AE, Deuschl G, Rezai AR (Eds). Mov. Disord.21(Suppl. 14) (2006).
  • Goodman RR, Kim B, McClelland S et al. Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry77, 12–17 (2006).
  • Gironell A, Kulisevsky J, Rami L, Fortuny N, Garcia-Sanchez C, Pascual-Sedano B. Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease. A controlled comparative study. J. Neurol.250, 917–923 (2003).
  • Russman H, Ghika J, Villemure JG et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology63, 1952–1954 (2004).
  • Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE. Long-term follow-up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J. Neurosurg.99, 489–495 (2003).
  • Kleiner-Fisman G, Herzog J, Fisman DN et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov. Disord. (Suppl. 14), S290–S304 (2006).
  • Ondo W, Jankovich J, Schwartz K, Almaguer M, Simpson RK. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson disease tremor. Neurology51, 1063–1069 (1998).
  • Chou KL, Forman MS, Trojanoski JQ, Hurtig HI, Baltuch GH. Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case Report. J. Neurosurg.100, 553–556 (2004).
  • Lyons KE, Wilkinson SB, Overman J, Pahwa R. Surgical and hardware complications of subthalamic stimulation: a series of 160 procedures. Neurology63(4), 612–616 (2004).
  • Hamani C, Richter E, Schwalb JM, Lozano AM. Bilateral subthalamic nucleus stimulation for Parkinson’s disease: a systematic review of the clinical literature. Neurosurgery56, 1313–1321 (2005).
  • Hilker R, Portman AT, Voges J et al. Disease progression continues in patients with advanced Parkinson’s disease and effective subthalamic nucleus stimulation. J. Neurol. Neurosurg. Psychiatry76, 1217–1221 (2005).
  • Krack P, Pollak P, Limousin P et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain121(Pt 3), 451–457 (1998).
  • Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson’s disease. Brain123, 2091–2108 (2000).
  • Meissner W, Schreiter D, Volkmann J et al. Deep brain stimulation in late-stage Parkinson’s disease: a retrospective cost analysis in Germany. J. Neurol.252, 218–223 (2005).
  • Bejjani BP, Gervais D, Arnuf I et al. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic nucleus stimulation. J. Neurol. Neurosurg. Psychiatry68, 595–600 (2000).
  • Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson’s disease. Arch. Neurol.62, 554–560 (2005).
  • Lagrange E, Krack P, Moro E et al. Bilateral subthalamic nucleus stimulation improves all aspects of health-related quality of life in Parkinson’s disease. Neurology59, 1976–1978 (2002).
  • Deuschl G, Schade-Brittinger C, Krack P et al. A randomized trial of deep brain stimulation for Parkinson’s disease. N. Engl. J. Med.355, 896–908 (2006).
  • Fahn S, Elton RL, and members of the UPDRS Development Committee. Unified Parkinson’s disease rating scale. In: Recent Developments in Parkinson’s Disease. Fahn S, Marsden CD, Goldstein M (Eds). Macmillan Health Care Information, NJ, USA (1987).
  • Molinuevo JL, Vallderiola F, Tolosa E et al. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch. Neurol.57, 983–988 (2000).
  • Valldeoriola F, Pileri M, Tolosa E, Molinuevo JL, Rumia J, Ferrer E. Bilateral subthalamic stimulation monotherapy in advanced Parkinosn’s disease: long-term follow-up of patients. Mov. Disord.17, 125–132 (2002).
  • Vingerhoets FJ, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J. Subthalamic deep brain stimulation replaces levodopa in Parkinson’s disease: two-year follow-up. Neurology58(3), 396–401 (2002).
  • Pawha R, Wilkinson SB, Overman J, Lyon KE. Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson’s disease. Stereotact. Funct. Neurosurg.83, 80–83 (2005).
  • Visser-Vandewalle V, Temel Y, Colle H, van der Linden C. Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy-parkinsonism. Report of four cases. J. Neurosurg.98, 882–887 (2003).
  • Krack P, Pollak P, Limousin P, Benazzouz A, Benabid AL. Stimulation of subthalamic nucleus alleviates tremor in Parkinson’s disease. Lancet350, 1675 (1997).
  • Capelle HH, Simpson RK, Kronnenbuerger M, Michaelson J, Tronnier V, Krauss JK. Long-term deep brain stimulation in elderly patients with cardiac pacemaker. J. Neurosurg.102, 53–59 (2005).
  • Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirement in Parkinson’s disease. Neurology53, 85–90 (1999).
  • Setiawa M, Kraft S, Doig K et al. Referrals for movement disorder surgery: under-representation of females and reasons for refusal. Can. J. Neurol. Sci.33, 53–57 (2006).
  • Morrison CE, Borod JC, Perrine K et al. Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson’s disease. Arch. Clin. Neurospychol.19, 165–181 (2004).
  • Hariz MI, Johansson F, Shamsgovara P, Johansson E, Hariz GM, Fagerlund M. Bilateral subthalamic nucleus stimulation in a parkinsonian patient with preoperative deficits in speech and cognition: persistent improvement in mobility but increased dependency: a case study. Mov. Disord.15, 136–139 (2000).
  • Trepanier LL, Kumar R, Lozano AM, Lang AE, Saint-Cyr JA. Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson’s disease. Brain Cogn.42, 324–347 (2000).
  • Allegret M, Junque C, Valldeoriola F et al. Effects of bilateral subthalamic stimulation on cognitive function in Parkinson’s disease. Arch. Neurol.58, 1223–1227 (2001).
  • Houeto JL, Mesnage V, Mallet L et al. Behavioral disorders, Parkinson’s disease and subthalamic nucleus stimulation. J. Neurol. Neurosurg. Psychiatry72, 701–707 (2002).
  • Levy G, Jacobs DM, Tang MX et al. Memory and executive function impairment predict dementia in Parkinson’s disease. Mov. Disord.17, 1221–1226 (2002).
  • Caparros-Lefebvre D, Blond S, Pecheux N, Pasquier F, Petit H. Neuropsychological evaluation before and after thalamic stimulation in 9 patients with Parkinson’s disease. Rev. Neurol.148, 117–122 (1992).
  • Troster AI, Fields JA, Wilkinson SB et al. Unilateral pallidal stimulation for Parkinson’s disease: neurobehavioral functioning before and 3 months after electrode implantation. Neurology49, 1078–1083 (1997).
  • Loher TJ, Gutbrod K, Fravi NL, Pohle T, Burgunder JM, Krauss JK. Thalamic stimulation for tremor. Subtle changes in episodic memory are related to stimulation per se and not to a microthalamotomy effect. J. Neurol.250, 707–713 (2003).
  • Ardouin C, Pillon B, Peiffer E et al. Bilateral subthalamic or pallidal stimulation for Parkinson’s disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann. Neurol.46, 217–223 (1999).
  • Pillon B, Ardouin C, Damier P et al. Neuropsychological changes between ‘off’ and ‘on’ STN or GPi stimulation in Parkinson’s disease. Neurology55, 411–418 (2000).
  • Daniele A, Albanese A, Contarino MF et al. Cognitive and behavioral effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry74, 175–182 (2003).
  • Funkiewiez A, Ardouin C, Caputo E et al. Long-term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behavior in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry75, 834–839 (2004).
  • Hershey T, Revilla FJ, Wernle A, Gibson PS, Dowling JL, Perlmutter JS. Stimulation of STN impairs aspects of cognitive control in Parkinson’s disease. Neurology62, 1110–1114 (2004).
  • Vingerhoets G, van der Linden C, Lannoo E et al. Cognitive outcome after unilateral pallidal stimulation in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry66, 297–304 (1999).
  • Volkmann J, Allert N, Voges J, Weiss PH, Sturm V. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced Parkinson’s disease. Neurology56, 548–551 (2001).
  • Burkhard PR, Vingerhoets FJ, Berney A et al. Suicide after successful deep brain stimulation for movement disorders. Neurology63, 2170–2172 (2004).
  • Voon V, Moro E, Saint-Cyr JA, Lozano AM, Lang AE. Psychiatric symptoms following surgery for Parkinson’s disease with an emphasis on subthalamic nucleus stimulation. In: Advances in Neurology (Volume 96). Behavioral Neurology of Movement Disorders. Anderson KE, Weiner WJ, Lang AE (Eds). Lippincott Williams and Wilkins, PA, USA, 130–147 (2005).
  • Witjas T, Baunez C, Henry JM et al. Addiction in Parkinson’s disease: impact of subthalamic nucleus deep brain stimulation. Mov. Disord.20, 1052–1055 (2005).
  • Herzog J, Volkmann J, Krack P et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease. Mov. Disord.18, 1332–1337 (2003).
  • Moro E, Esselink RA, Van Blercom N et al. Bilateral subthalamic nucleus stimulation in a parkinsonian patient with previous unilateral pallidotomy and thalamotomy. Mov. Disord.15, 753–755 (2000).
  • Fraix V, Pollak P, Moro E et al. Subthalamic nucleus stimulation in tremor-dominant patients with previous thalamic surgery. J. Neurol. Neuropsych. Psychiatry76, 246–248 (2005).
  • Kleiner-Fisman G, Fisman DN, Zamir O et al. Subthalamic nucleus deep brain stimulation for Parkinson’s disease after successful pallidotomy: clinical and electrophysiological observations. Mov. Disord.19, 1209–1214 (2004).
  • Volkmann J, Allert N, Voges J, Sturm V, Schnitzler A, Freund HJ. Long-term results of bilateral pallidal stimulation in Parkinson’s disease. Ann. Neurol.55, 871–875 (2004).
  • Broggi G, Franzini A, Ferroli P et al. Effect of bilateral subthalamic electrical stimulation in Parkinson’s disease. Surg. Neurol.56, 89–94 (2001).
  • Peppe A, Pierantozzi M, Bassi A et al. Stimulation of the subthalamic nucleus compared to the globus pallidus internus in patients with Parkinson’s disease. J. Neurosurg.101, 195–200 (2004).
  • Hariz MI, Bergenheim AT. A comparative study on ventriculography and computerized tomography-guided determination of brain targets in functional stereotaxis. J. Neurosurg.73, 565–571 (1990).
  • Starr PA. Placement of deep brain stimulators into the subthalamic nucleus or globus pallidus internus: technical approach. Stereotact. Funct. Neurosurg.79, 18–145 (2002).
  • Simon SL, Douglas P, Batuch GH, Jaggi JL. Error analysis of MRI and Leksell stereotactic frame target localization in deep brain stimulation surgery. Stereotact. Funct. Neurosurg.83, 1–5 (2005).
  • Cohen DS, Lustgarten JH, Miller E. Effects of coregistration of MR to CT images on MR stereotactic accuracy. J. Neurosurg.82, 772–779 (1995).
  • Benazzouz A, Breit S, Koudsie A, Pollak P, Krack P, Benabid AL. Intraoperative microrecording of the subthalamic nucleus in Parkinson’s disease. Mov. Disord.17(Suppl. 3), S145–S149 (2002).
  • Hariz MI. Safety and risk of microelectrode recording in surgery for movement disorders. Stereotact. Funct. Neurosurg.78, 146–157 (2002).
  • Pollak P, Krack P, Fraix V et al. Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson’s disease. Mov. Disord.17(Suppl. 3), S155–S161 (2002).
  • Volkman J, Herzog J, Kopper F, Deuschl G. Introduction to the programming of deep brain stimulation. Mov. Disord.17(Suppl. 3), S181–S187 (2002).
  • Dowsey-Limousin P. Post-operative management of Vim DBS for tremor. Mov. Disord.17(Suppl. 3), S208–S211 (2002).
  • Krack P, Fraix V, Mendes A, Benabid AL, Pollak P. Postoperative management of subthalamic nucleus stimulation for Parkinson’s disease. Mov. Disord.17(Suppl. 3), S155–S161 (2002).
  • Kumar R. Methods for programming and patient management with deep brain stimulation of the globus pallidus for the treatment of advanced Parkinson’s disease and dystonia. Mov. Disord.17(Suppl. 3), S198–S207 (2002).
  • Moro E, Poon YY, Saint-Cyr JA, Lozano AM, Lang AE. Subthalamic nucleus stimulation: improvement in outcome with reprogramming. Arch. Neurol.63, 1266–1272 (2006).
  • Grill WM. Safety consideration for deep brain stimulation: review and analysis. Exp. Rev. Med. Devices2, 409–420 (2005).
  • Funkiewiez A, Ardouin C, Krack P et al. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson’s disease. Mov. Disord.18, 524–530 (2003).
  • Mazzone P, Lozano AM, Stanzione P et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson’s disease. Neuroreport16, 1877–1881 (2005).
  • Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson’s disease. Neuroreport16, 1883–1887 (2005).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.